Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the french society of paediatric oncology

This publication has 12 references indexed in Scilit:

• Treatment of osteosarcoma with ifosfamide: Comparison of response in pediatric patients with recurrent disease versus patients previously untreated: A pediatric oncology group study
  Medical and Pediatric Oncology, 1995
• Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A pediatric oncology group phase II study
  Cancer, 1993
• The Importance of Dose-Intensity in Neoadjuvant Chemotherapy of Osteosarcoma: A retrospective analysis of high-dose methotrexate, cisplatinum and adriamycin used preoperatively
  Journal of Chemotherapy, 1990
• Clinical trial of etoposide (VP-16) in children with recurrent malignant solid tumors
  Investigational New Drugs, 1988
• Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.
  Journal of Clinical Oncology, 1988
• Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.
  Journal of Clinical Oncology, 1987
• A phase II study of ifosfamide in children with recurrent solid tumours
  Cancer Chemotherapy and Pharmacology, 1985
• Ifosfamide and vincristine in paediatric tumours. A phase II study
  European Paediatric Haematology and Oncology, 1984
• Epipodophyllotoxin VP 16213 in Treatment of Acute Leukaemia--Haematosarcoma and Solid Tumours
  BMJ, 1973
• The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent
  Journal of Chronic Diseases, 1961